Rankings
▼
Calendar
BCRX FY 2010 Earnings — BioCryst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
BCRX
BioCryst Pharmaceuticals, Inc.
$2B
FY 2010 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$64M
-14.9% YoY
Gross Profit
$63M
99.9% margin
Operating Income
-$33M
-52.3% margin
Net Income
-$33M
-51.5% margin
EPS (Diluted)
$-0.73
Cash Flow
Operating Cash Flow
-$29M
Free Cash Flow
-$29M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$111M
Total Liabilities
$44M
Stockholders' Equity
$67M
Cash & Equivalents
$14M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$64M
$75M
-14.9%
Gross Profit
$63M
$70M
-9.5%
Operating Income
-$33M
-$14M
-141.9%
Net Income
-$33M
-$13M
-143.3%
← FY 2009
All Quarters
FY 2011 →